Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35482927

Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood Adv
Publication date
2023 Feb 28
First author
Lamble AJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Lamble AJ
      type
      Author
    2. name
      Myers RM
      type
      Author
    3. name
      Taraseviciute A
      type
      Author
    4. name
      John S
      type
      Author
    5. name
      Yates B
      type
      Author
    6. name
      Steinberg SM
      type
      Author
    7. name
      Sheppard J
      type
      Author
    8. name
      Kovach AE
      type
      Author
    9. name
      Wood B
      type
      Author
    10. name
      Borowitz MJ
      type
      Author
    11. name
      Stetler-Stevenson M
      type
      Author
    12. name
      Yuan CM
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Lamble AJ
      type
      Author
    2. name
      Myers RM
      type
      Author
    3. name
      Taraseviciute A
      type
      Author
    4. name
      John S
      type
      Author
    5. name
      Yates B
      type
      Author
    6. name
      Steinberg SM
      type
      Author
    7. name
      Sheppard J
      type
      Author
    8. name
      Kovach AE
      type
      Author
    9. name
      Wood B
      type
      Author
    10. name
      Borowitz MJ
      type
      Author
    11. name
      Stetler-Stevenson M
      type
      Author
    12. name
      Yuan CM
      type
      Author
    bibliography ids
    1. nci-bib-da63157f8125e243d143b17a
    book metadata
    content sha256
    bcb58d11db0af252146920213ea222e3fa132aeda7611e30990ab7cd50ec3837
    document type
    citation
    dois
    1. 10.1182/bloodadvances.2022007423
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:35482927
    immutable id
    pubmed:35482927@bcb58d11db0af252146920213ea222e3fa132aeda7611e30990ab7cd50ec3837
    journal
    abbreviation
    Blood Adv
    issn electronic
    2473-9537
    issn print
    2473-9529
    issue
    4
    name
    Blood advances
    nlm unique id
    101698425
    pages
    575-585
    volume
    7
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      35482927
      provenance
      batch id
      9d150d55960e0c12aada
      provider
      NCBI PubMed ESummary
      record sha256
      1d501cb0d89ec30db9fbb508306278c74e4a2bc04d821e088df14b1109816bf1
      response sha256
      2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
      retrieved at
      2026-09-09T23:48:09.820498+00:00
      publication date
      display
      2023 Feb 28
      precision
      day
      year
      2023
      publication types
      1. Journal Article
      2. Multicenter Study
      3. Research Support, N.I.H., Extramural
      4. Research Support, N.I.H., Intramural
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/35482927/
      title
      Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.

      Preserved source evidence · Not medical advice